Abstract
Hematopoietic stem cell (HSC) transplants are widely used to treat patients with cancer and other disorders of the blood and immune system. The isolation of human HSC offers the promise for obtaining a remarkable variety of new therapeutics. Thus, an effort to analyze and assess the safety of these cells is extremely important. As with blood transfusion, microbial infections have been transmitted by HSC transplantation. Due to the inability to sterilize HSC and the immunodeficient nature of their recipients, the risk of infectious disease transmission remains a major concern. Assessing HSC safety requires careful monitoring of their collection, manipulation, and distribution. This review describes the pathogens that are recovered from HSC products, and the approaches available for detecting microbial contamination in HSC products prior to transplant.
| Original language | English |
|---|---|
| Pages (from-to) | 17-27 |
| Number of pages | 11 |
| Journal | Reviews and Research in Medical Microbiology |
| Volume | 18 |
| Issue number | 2 |
| DOIs | |
| State | Published - Apr 2007 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Bone marrow transplant
- Hematopoietic stem cell
- Microbial contamination
- Transfusion
Fingerprint
Dive into the research topics of 'Microbial pathogens of hematopoietic stem cells - Screening and testing for infectious diseases'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver